(Q39301423)

10 September 2017

title

Flotillins as regulators of ErbB2 levels in breast cancer (English)

1 reference

10 September 2017

8

K Liestøl

1 reference

10 September 2017

S Pust

1

1 reference

10 September 2017

T I Klokk

2

1 reference

10 September 2017

N Musa

3

1 reference

10 September 2017

M Jenstad

4

1 reference

10 September 2017

B Risberg

5

1 reference

10 September 2017

B Erikstein

6

1 reference

10 September 2017

L Tcatchoff

7

1 reference

10 September 2017

H E Danielsen

9

1 reference

10 September 2017

B van Deurs

10

1 reference

10 September 2017

K Sandvig

11

1 reference

10 September 2017

language of work or name

English

0 references

publication date

6 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

32

1 reference

10 September 2017

issue

29

1 reference

10 September 2017

page(s)

3443-3451

1 reference

The ErbB signaling network: receptor heterodimerization in development and cancer

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

A quantitative protein interaction network for the ErbB receptors using protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Evolving novel anti-HER2 strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Scaffolding microdomains and beyond: the function of reggie/flotillin proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Interplay between toxin transport and flotillin localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Direct observation of individual endogenous protein complexes in situ by proximity ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Regulation of aurora B kinase by the lipid raft protein flotillin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Research advances on flotillins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Flotillin-1 stabilizes caveolin-1 in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

ErbB2 degradation mediated by the co-chaperone protein CHIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Flotillin-1/reggie-2 protein plays dual role in activation of receptor-tyrosine kinase/mitogen-activated protein kinase signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Molecular networks in FGF signaling: flotillin-1 and cbl-associated protein compete for the binding to fibroblast growth factor receptor substrate 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

FOXO1A is a target for HER2-overexpressing breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

A Phase I Study of Cetuximab/Paclitaxel in Patients with Advanced-Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.357

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.357

1 reference

release_6ft5d7hykva2vdvdqwz66btn3q

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ft5d7hykva2vdvdqwz66btn3q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference